Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma  by Scanu, Tiziana et al.
Article
SalmonellaManipulation of Host Signaling Pathways
Provokes Cellular Transformation Associated with
Gallbladder CarcinomaGraphical AbstractHighlightsd Gallbladder cancer (GBC) in India has unique mutations and
is marked by S. Typhi DNA
d Salmonella is sufficient to transform genetically susceptible
mice, organoids, and MEFs
d Transformation follows Salmonella manipulation of AKT and
MAPK pathways during infection
d Salmonella infection imprints sustained transformation, as in
GBC patients from IndiaScanu et al., 2015, Cell Host & Microbe 17, 763–774
June 10, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.chom.2015.05.002Authors
Tiziana Scanu, Robbert M. Spaapen,
JeroenM. Bakker, ..., DavidW. Holden,





Salmonella Typhi infection is associated
with gallbladder carcinoma (GBC), a
frequent tumor in India and rare in the
Western world. Scanu et al. show that by
activating AKT and MAPK pathways
during infection, Salmonella irreversibly
transforms mice, gallbladder organoids,
and MEFs with mutated TP53 and
amplified c-MYC, as observed in GBC
patients from India.Accession NumbersGSE59623
Cell Host & Microbe
ArticleSalmonellaManipulation of Host Signaling Pathways
Provokes Cellular Transformation
Associated with Gallbladder Carcinoma
Tiziana Scanu,1,10,* Robbert M. Spaapen,1,10 JeroenM. Bakker,1,10 Chandra Bhan Pratap,2,10 Lin-enWu,1 Ingrid Hofland,3
Annegien Broeks,3 Vijay Kumar Shukla,4 Mohan Kumar,5 Hans Janssen,1 Ji-Ying Song,6 E. Andra Neefjes-Borst,7
Hein te Riele,8 David W. Holden,9 Gopal Nath,2 and Jacques Neefjes1,*
1Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands
2Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
3Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam,
the Netherlands
4Department of General Surgery
5Department of Pathology
Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
6Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands
7Department of Pathology, Free University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands
8Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands
9Center for Molecular Bacteriology and Infection, Imperial College London, London SW72AZ, UK
10Co-first author
*Correspondence: t.scanu@nki.nl (T.S.), j.neefjes@nki.nl (J.N.)
http://dx.doi.org/10.1016/j.chom.2015.05.002SUMMARY
Cancer is fueled by deregulation of signaling path-
ways in control of cellular growth and proliferation.
These pathways are also targeted by infectious path-
ogens en route to establishing infection. Gallbladder
carcinoma (GBC) is frequent in the Indian subconti-
nent, with chronic Salmonella enterica serovar Typhi
infection reported as a significant risk factor. How-
ever, direct association and causal mechanisms
between Salmonella Typhi infection and GBC have
not been established. Deconstructing the epidemio-
logical association between GBC and Salmonella
Typhi infection, we show that Salmonella enterica
induces malignant transformation in predisposed
mice, murine gallbladder organoids, and fibroblasts,
with TP53 mutations and c-MYC amplification.
Mechanistically, activation of MAPK and AKT path-
ways, mediated by Salmonella enterica effectors
secreted during infection, is critical to both ignite
and sustain transformation, consistent with observa-
tions in GBC patients from India. Collectively, our
findings indicate that Salmonella enterica can pro-
mote transformation of genetically predisposed cells
and is a causative agent of GBC.
INTRODUCTION
Cancer is amajor cause of deathworldwide. Strikingly, somecan-
cer types have a unique global distribution such as gallbladder
carcinoma (GBC), which is frequent in India and Pakistan, butCell Hrare in the Western world (Hundal and Shaffer, 2014). In India,
GBC represents the third most common gastrointestinal tumor
with reported incidence rates of 22/100,000 persons (Crump
et al., 2004; Nath et al., 2008; Randi et al., 2006). The prognosis
of GBC is poor, and definition of causal factors underlying its
unique global distribution may provide rationale for combatting
this tumor (Hundal andShaffer, 2014;Lazcano-Ponceetal., 2001).
Various factors are proposed to explain the peculiar global
distribution of GBC cases. Especially chronic Salmonella
enterica serovar Typhi (S. Typhi) infection, but also gallstones
and chronic gallbladder inflammation (cholelithiasis) are re-
ported risk factors for GBC (Wistuba and Gazdar, 2004). In
the absence of causal molecular explanations such associa-
tions are insufficient for implementation in cancer prevention
programs.
S. Typhi is endemic in India causing typhoid fever. A small per-
centage of the infected patients become chronic carriers when
S. Typhi enters the gallbladder, where it propagates to shed
new bacteria into the intestinal tract to spread infection (Ruby
et al., 2012). Chronic typhoid carriers have a 9-fold greater
risk for developing GBC (Shukla et al., 2000). Because molecular
understanding of the mechanism(s) underlying this correlation
is lacking, a contribution of chronic S. Typhi infection to
cancer formation is not generally accepted (Nagaraja and Eslick,
2014).
While viruses are among the established causal factors for
particular cancers (Chang, 2014; Coghill and Hildesheim, 2014;
Doorbar et al., 2012), bacteria are largely ignored as direct con-
tributors for they fail to integrate their DNA into the host genome
and do not leave a genetic imprint in the resulting tumors. Never-
theless, contribution of bacterial infection to cancer develop-
ment has been suggested based on various epidemiological
studies (Mager, 2006; Samaras et al., 2010). Most accepted is
the link between Helicobacter pylori and gastric cancer (Polkost & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc. 763
Figure 1. Salmonella Typhi Infection and
GBC: India versus the Netherlands
(A) Representative images of a human GBC sam-
ple from India. IHC for detections of Cytokeratin-8
(left), TP53 (center), and c-MYC (right). The sec-
tions are counterstained by hematoxylin for
detection of nuclei (in blue). Scale bar, 25 mm.
(B) IHC of a representative GBC sample from the
Netherlands stained for Cytokeratin-8 (left), TP53
(center), and c-MYC (right). The sections are
counterstained by hematoxylin for detection of
nuclei (in blue). Scale bar, 25 mm.
(C) Detection of serum antibodies against S. Typhi
(ViAb) in patients affected by benign gallbladder
disease (benign, 11.6%; n = 60) or GBC (carci-
noma, 52.2%; n = 23). Statistical significance
determined by c2 test. ***p < 0.001.
(D) Percentage of gallbladder tissue containing fliC
DNA of S.Typhi collected in India from control
population (control, 5.33%; n = 150), patients
with benign gallbladder diseases (benign, 39.6%;
n = 187), or GBC (carcinoma, 74.1%; n = 54). Right
panel, PCR amplification of S. Typhi fliC DNA in
GBC sample (indicated as ‘‘Tumor’’) compared
with control DNA from S. Typhi reference strain
(indicated as ‘‘C’’). Statistical significance deter-
mined by c2 test. ***p < 0.001. See also Figure S1
and Table S1.and Peek, 2010). Mycobacterium tuberculosis has also been
associated with lung cancer (Kuo et al., 2013), while Chlamydia
trachomatis (Arnheim Dahlstro¨m et al., 2011; Koskela et al.,
2000; Shanmughapriya et al., 2012) and Chlamydia pneumonia
have been linked to cervical and lung cancer, respectively (Cha-
turvedi et al., 2010; Zhan et al., 2011).
How bacteria may contribute to cancer is poorly understood,
and multiple mechanisms have been proposed. Sustained
inflammation may contribute, for example, by continuous activa-
tion of MYD88 (Elinav et al., 2013). On the other side the toxin
CagA derived from H. pylori activates signaling through the
Met receptor, but it remains unclear whether this suffices to
induce gastric carcinoma (Hatakeyama, 2014; McCracken
et al., 2014). Since only a fraction of all individuals infected
with H. pylori develop gastric cancer, additional factors are likely
to influence cancer formation. Bacteria can also manipulate the
host epigenome. For example, Listeria, Shigella, Mycobacteria,
and Chlamydia may modify chromatin structure and histone
modifications (Schmeck et al., 2008) of host cells and then alter
the host transcriptome (Chumduri et al., 2013; Hamon and Cos-
sart, 2008) with unknown consequences to tumorigenesis.
Salmonella enterica serovar Typhimurium (S. Typhimurium)
secretes more than 40 different effector proteins into host cells
through its type III secretion system (TTSS) in support of its infec-
tion cycle (McGhie et al., 2009; Thomas et al., 2012). These pro-764 Cell Host & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc.teins are either directly endowed with
enzymatic activities or function as critical
modulators of host enzymes, all of which
may in principle contribute to transforma-
tion. Although epidemiology suggests
that infection by bacteria cannot be a
single cause for tumor formation, it is
possible that bacteria can clear one key hurdle in the multistep
process toward transformation.
Here we show that S. Typhimurium bacteria can directly
induce cellular transformation in gallbladder organoids and
mouse embryonal fibroblasts (MEFs) adding to specific pre-
transforming mutations in the host. These predisposing muta-
tions required for S. Typhimurium -induced transformation are
also observed in GBC samples from India, along with the DNA
of S. Typhi. We conclude that cellular transformation mediated
by Salmonella enterica occurs through activation of host path-
ways that promote bacterial uptake and intracellular survival.
Transformation of cells is then the result of collateral damage
induced by Salmonella enterica during its infection cycle.
Because other bacteria are also known to activate these host
pathways in their infection cycle, our observations may have
broader implications.
RESULTS
Salmonella Typhi andGBC: India versus theNetherlands
GBC is rare in the Western world, unlike in India and Pakistan
(Hundal and Shaffer, 2014). To assess whether GBC samples
collected in India or the Netherlands are different in nature, we
examined tissue sections for a series of markers by immunohis-
tochemistry (IHC) (Figures 1A and 1B). Carcinomas from both
Figure 2. Salmonella Infection Drives
Tumor Development in Predisposed Mice
(A) Kaplan-Meier curve of symptom-free survival
of Apc+/min and WT mice infected or not ()
with WT or PrgH deletion mutant (DprgH) S.
Typhimurium. p < 0.001 as defined by a log-
rank (Mantel-Cox) test. Right, representative
images of bleeding anus (top) and rectal prolapse
(bottom).
(B) Pathology assessment of colorectal trans-
formation occurring in WT or Apc+/min (APC+/min)
mice infected with WT, DprgH S. Typhimurium, or
not infected (). Red diamonds, mice with symp-
toms as indicated in Figure 2A. Black diamonds,
mice with no symptoms. p = 0.0109 by Fisher’s
exact test.
(C) Representative case of H&E-stained adeno-
carcinoma sections from the distal colon of an
Apc+/min mouse infected with WT S. Typhimu-
rium. The tumor is moderately-to-poorly differ-
entiated with invasion of submucosa, muscu-
laris, and serosa of the colon. Scale bars: top
panel, 500 mm; bottom panel, 50 mm. See also
Figure S2.groups stained positive for Cytokeratin-8 (a secretory epithelial
differentiation marker) and TP53 (shown by a strong nuclear
signal as mutated inactive TP53 aggregates), confirming earlier
observations (Wistuba andGazdar, 2004). By contrast, a marked
geographical difference emerged for c-MYC, which presented
strongly nuclear staining in 9/10 Indian samples, while only 1/6
patient samples from the Netherlands contained a small number
of positive cells. The other five Dutch patients did not show
c-MYC staining (Figures 1A and 1B; Table S1), suggesting that
GBC tumors from India and the Netherlands are different in
nature.
The high incidence of GBC reported in India correlates with
higher prevalence of chronicS. Typhi carriers that can be defined
by antibodies against S. Typhi (ViAb) in patient serum (Nath et al.,
2008). Analysis of sera from 23 GBC and 60 control individuals
(with benign gallbladder diseases) showed a clear correlation
between serum antibodies detecting a history of chronicS. Typhi
infection and GBC (Figure 1C), with 53% of GBC positive for
ViAb, versus 11.6% of benign gallbladder samples. However,
not all chronic patients may develop such antibodies. We there-
fore scored collected GBC samples for S. Typhi DNA as an indi-
cation of S. Typhi infection (Nath et al., 2008; Pratap et al., 2013).
In tissues collected from Indian patients, DNA for S. Typhi fliC
and staA (Pratap et al., 2013) was detected in 74% of GBCs,
as compared to 40% of tissues from patients with benign gall-
bladder disease (including cholelithiasis) and6%of gallbladder
tissues from healthy controls with no diagnosed gallbladder
disease (control samples) (Figure 1D; Table S1; Figure S1).
Importantly, DNA for S. Typhi was not detected in any of the
GBC samples collected in the Netherlands (Table S1). On this
basis, GBC samples from India differed markedly from those
from the Netherlands.Cell HSalmonella enterica Infection in Apc+/min Mice Induces
Colon Tumors
Because only a fraction of S. Typhi-infected persons in India
develop GBC, S. Typhi cannot be a single causal factor of tumor-
igenesis. S. Typhi may, however, contribute one step in the
multistep process leading up to cancer. To test whether pre-
transforming mutations in the host (as defined above) can coop-
erate with Salmonella enterica bacteria in cancer formation, we
used mice heterozygous for Apc (Apc+/min) that induces c-Myc
overexpression (de Wind et al., 1998) to mimic the correspond-
ing phenotype of GBC samples from India. The Apc+/min
mice were infected with S. Typhimurium (hereafter referred to
as Salmonella) that causes typhoid-like disease in mice
(Santos et al., 2001). To assess any contribution of a pre-trans-
formed state to cancer formation, we infected either control or
Apc+/min mice with Salmonella. As a further control, we infected
Apc+/min and control mice with the Salmonella mutant DprgH,
which is unable to inject effector proteins into the host cytosol
due to lack of a functional TTSS (Behlau and Miller, 1993). Of
note, the DprgH mutant Salmonella can shed LPS and when
eliminated expose factors including lipoteichoic acid and bacte-
rial DNA to mediate TLR-dependent inflammatory responses
(Kaur and Jain, 2012). All mice were pretreated with strepto-
mycin to eliminate the commensal gut flora and allow Salmonella
infection (Barthel et al., 2003). The next day, the mice were orally
infected with equal numbers of wild-type (WT) or DprgH Salmo-
nella and then monitored over time. At 4–7 months post-infec-
tion, nearly half of the Apc+/min mice infected withWT Salmonella
presented with bleeding anus and stool or rectal prolapse
(Figure 2A; indicated as symptoms). At the age of 50 weeks,
all mice were examined by pathology in a blinded fashion.
In addition to the expected development of small intestinalost & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc. 765
Figure 3. Salmonella Infection of Gall-
bladder Organoids Induces Cell Transfor-
mation
(A) Top panel, representative wide-field micro-
scopy image of a gallbladder organoid culture.
Bottom panel, confocal images of one represen-
tative gallbladder organoid infected with S. Ty-
phimurium (in red). Nuclei are stained with DAPI
(blue), and actin is shown in green (scale bar,
25 mm). Z stack projections of gallbladder orga-
noids, see Movie S1.
(B) Gallbladder organoid cells with a history of S.
Typhimurium infection (Salmonella infected, bot-
tom panels) or not (not infected, top panels) were
cultured to reform organoids in complete medium
(left panels) or supplements-depleted medium
(right panels). Representative images of organoids
culture from two independent experiments per-
formed in triplicate are shown.
(C) H&E staining (top) and E-cadherin IHC (bottom)
of gallbladder organoids grown from cells infected
(right panels) or not (left panels) with S. Typhimu-
rium. The sections are counterstained by hema-
toxylin. Scale bar, 20 mm. See also Figure S3 and
Movie S1.adeno(carcino)mas due to the Apc+/min background (Figures
S2A–S2C), colorectal adenocarcinomas were observed in
symptomatic Apc+/min mice infected with WT Salmonella (Fig-
ures 2B and 2C). These tumors were observed only once in
each of our control conditions (Figures 2A and S2C). These
experiments demonstrate that Salmonella can promote carcino-
genesis in vivo in the background of pre-transformation by
c-Myc oncogene overexpression resulting from loss of one
copy of the APC gene. Since Salmonella lacking TTSS (DprgH)
failed to induce colon carcinomas, these experiments suggest
that host cell manipulation by Salmonella is critical to bacterially
mediated transformation.
Salmonella enterica Infection of Gallbladder Organoids
Induces Cell Transformation
In order to test the potential primary contribution of Salmonella
to transformation, we explored a minimal, yet still relevant,
model system. We chose to test organoids derived from pre-
transformed murine gallbladders. Gallbladder organoids were
cultured from gallbladders of mice deficient in the Ink4b-Arf-
Ink4a locus, thereby presenting with inactive TP53 to resemble
the analogous situation in GBC patients (Krimpenfort et al.,766 Cell Host & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc.2007) (Figure 3A). These gallbladder or-
ganoids were generated under intestinal
organoid culture conditions (Koo et al.,
2012; Sato et al., 2009) lacking Noggin
and R-spondin supplements, which in
contrast to the intestinal organoids
delayed the growth of these gallbladder
organoids. The gallbladder organoids
were characterized by staining for epithe-
lial markers E-cadherin andCytokeratin-8
(Figures 3C and S3A), showing an orga-
nized epithelial cell layer. Electron micro-
scopy revealed polarized cells with microvilli on the apical
surface facing the lumen (Figure S3B), similar to those reported
in gallbladder organs (Frierson, 1989). Taken together, all tests
showed that the organoids exhibit the epithelial layer character-
istic of gallbladder organs.
To conduct Salmonella infections in the organoid system, sin-
gle cells derived from gallbladder organoids were infected with
WT or with DprgHmutant Salmonella and subsequently cultured
to allow de novo organoid formation (Figures 3A, 3B, and S3D;
Movie S1). These new gallbladder organoids were once again
dissociated into single cells for culturing under either normal or
supplement-depleted growth conditions (Koo et al., 2012; Sato
et al., 2009). Cells derived from gallbladder organoids with a
history ofWTSalmonella infectionwere able to form neworgano-
ids even under growth factor-restricted conditions, unlike the
cells infected with DprgH mutant Salmonella or never exposed
to Salmonella, which required supplements for growth (Figures
3B and S3D).
Acquired growth factor independency is one of the hall-
marks of transformation, as are altered cell morphology and
polarity. To visualize this, we performed pathology of infected
and control gallbladder organoids. H&E and epithelial marker
Figure 4. Salmonella Infection of Primary
Pre-transformed Fibroblasts Induces Cell
Transformation
(A) Representative images of the anchorage-
independent assay of WT (top panels), WT
overexpressing c-MYC (WT+cMyc; second
panels), Arf-deficient (Arf/+Empty vector
[EV]; third panels), and Arf-deficient over-
expressing c-MYC (Arf/+cMyc; bottom
panels) MEFs either infected (right) or not
(left) with S. Typhimurium. Images are repre-
sentative of at least three independent ex-
periments with technical triplicates. Scale bar,
200 mm.
(B) Number of soft agar colonies/well formed by S.
Typhimurium-infected (black bars) and not-in-
fected (white bars) MEFs. The genetic status
of the MEFs is indicated below the bars.
Results are representative of at least three inde-
pendent experiments with technical triplicates.
One-way ANOVA with a post hoc Bonferroni test
on selected sets was performed to test for sig-
nificance of all three factors for transformation.
***p < 0.001.
(C) Tumor growth in immunodeficient Rag1/
gc/ mice subcutaneously transplanted with S.
Typhimurium-infected MEFs after ciprofloxacin
treatment (Salmonella + ciprofloxacin, n = 3 mice)
or with not-infected MEFs (Not infected, n = 4
mice). Shown are mean tumor size ± SD. Unpaired
two-sided Student’s t test was applied. *p < 0.05;
**p < 0.01.
(D) GFP IHC (brown) of one representative
solid tumor formed by the MEFs (Arf /
overexpressing c-Myc-IRES-GFP with a history of S. Typhimurium infection) transplanted in Rag1/gc/ mice. The sections were counterstained by he-
matoxylin for detection of the nuclei (in blue). Scale bar, 500 mm. See also Figures S4A–S4C.staining revealed that the gallbladder organoids infected with
Salmonella lost their cohesion and polarity and presented
large irregular nuclei with prominent nucleoli (Figure 3C).
These observations illustrate histopathological features of
neoplastic transformation confirmed by electron microscopy
analysis. Gallbladder organoids never exposed to Salmonella
exhibited normal epithelial organization and showed no signs
of transformation (Figures 3C, S3A, and S3C). These observa-
tions indicate that Salmonella bacteria can drive cellular trans-
formation against a predisposed genetic background, even
when immune cells and the resulting inflammatory responses
are absent.
Salmonella enterica Infection of Primary Pre-
transformed Fibroblasts Induces Cell Transformation
To understand the molecular basis of the interplay between
Salmonella infection and genetic predisposition in the process
of cell transformation, we used MEFs with different degrees of
pre-transforming alterations. We selected MEFs lacking Arf
(resulting in TP53 inactivation) and overexpressing c-MYC
(Arf/ + cMyc) to resemble conditions identified in human
GBC from India (Figure 1A). WT MEFs, as well as Arf-deficient
MEFs, were used as control. The MEFs harboring different
mutations were infected with Salmonella, and transformation
was assessed by colony formation in anchorage-indepen-
dent (soft agar) assays. Salmonella only induced significantCell Hnumbers of colonies in MEFs harboring at least two pre-trans-
forming mutations: Arf deficiency and overexpression of
c-MYC (Figures 4A and 4B). Similar results were obtained
when MEFs with the same pre-transforming mutations
were infected with S. Typhi, suggesting that both serovars,
S. Typhi and S. Typhimurium, induce transformation of pre-
transformed cells (Figure S4A). Since Arf deletion or c-MYC
overexpression alone did not induce colony formation over
background levels, this also defines the minimal pre-trans-
forming requirements for Salmonella-induced transformation
in this system and resembled the mutations observed in
GBC patients from India.
To confirm that the MEFs were transformed following Sal-
monella infection, we transplanted the cells isolated from
soft agar colonies into immune-deficient Rag1/gc/ mice
(Rygaard and Povsen, 2007). First, Salmonella was eliminated
from isolated MEFs with the antibiotic ciprofloxacin (Fig-
ure S4B), as immune-deficient mice are intolerant to bacterial
infection. Subsequently, equal numbers of Arf/ + cMyc
MEFs with or without a history of Salmonella infection were im-
planted into the mice. The growth of solid tumors was followed
in time (Figure 4C), revealing that only the MEFs isolated from
soft agar colonies induced by Salmonella infection produced
tumors in mice, and histopathology analysis showed high
mitotic incidence of the tumors with necrotic areas (Figures
4D and S4C).ost & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc. 767
Figure 5. Salmonella-Mediated Activation
of Akt and Map Kinase Pathways Drives
Transformation in Pre-transformed Cells
(A) Number of soft agar colonies/well formed by
Arf/+cMyc MEFs either or not infected with WT
or mutant DprgH (DprgH) S. Typhimurium. Results
are representative of three independent experi-
ments. Shown is mean ± SD of technical triplicate
experiment. Statistical significance by Student’s
t test; **p < 0.01.
(B) Number of soft agar colonies/well formed
by Arf/+cMyc MEFs infected with WT and
sopBsopEsopE2sptP S. Typhimurium. Re-
sults are representative of at least two indepen-
dent experiments with technical triplicates. Shown
are mean number of colonies ± SD from duplicate
experiments. Statistical significance by Student’s
t test; *p < 0.05.
(C) Number of soft agar colonies/well from S. Ty-
phimurium-infected Arf/+cMyc MEFs cultured
in the presence (+) or absence () of MAPK in-
hibitor AZD6244. Shown are mean number of
colonies ± SD from triplicate samples. Statistical
significance by Student’s t test, **p < 0.01.
(D) Number of soft agar colonies/well fromWT and
DsopB S. Typhimurium-infected Arf/+cMyc
MEFs. Shown are mean number of colonies ± SD
from triplicate experiments. Statistical significance
by Student’s t test; **p < 0.01.
(E) Number of soft agar colonies/well from S.
Typhimurium-infected (WT) Arf/+cMyc MEFs
cultured in the presence (+) or absence () of Akt
inhibitor AKTVIII. Shown are mean number of
colonies ± SD from triplicate samples. Statistical
significance by Student’s t test; **p < 0.01.
(F) Number of soft agar colonies/well from not-in-
fected or S. Typhimurium-infected (WT) Arf/+
cMyc MEFs that were cultured in the presence (+)
or absence () of MAPK inhibitor (AZD6244), Akt
inhibitor (AKTVIII), or a combination of these in-
hibitors. Shown are mean number of colonies ± SD
from triplicate samples. Statistical significance by
Student’s t test; **p < 0.01; ***p < 0.001.
(G) Number of soft agar colonies/well formed by
Arf-deficient MEFs overexpressing a control
empty vector containing GFP (Arf/) or Arf-defi-
cient MEFs overexpressing c-MYC (MYC). These
MEFs were either expressing a constitutively
active form of Akt1 (myrAKT1) or empty control vector (EV). The MEFs were treated (+) or not treated () with Akt inhibitor AKTVIII. Results are representative of
three independent experiments with technical triplicates. Shown are mean ± SD. Statistical significance by Student’s t test; **p < 0.01; ***p < 0.001.
(H) Western blot detecting phosphorylated Mapk (p-Mapk, top panel), total Mapk (center panel), and Actin (loading control, bottom panel) in Arf/+cMyc
MEFs that were either uninfected (Salmonella ) and not treated with MAPK inhibitor AZD6244 (left) or infected with S. Typhimurium (Salmonella +) in absence
(, center) or presence (+) of MAPK inhibitor AZD6244 (right).
(I) Western blot for detection of phosphorylated Akt signal in Arf/+cMyc MEFs either uninfected () without Akt inhibitor AKTVIII (left) or infected with S.
Typhimurium (Salmonella) in the absence (, center) or presence of AKTVIII (+, right). See also Figures S4D–S4F and S5.Salmonella enterica-MediatedActivation of Akt andMap
Kinase Pathways Drives Transformation
How then does Salmonella facilitate cellular transformation?
When pre-transformed MEFs were exposed to DprgH Salmo-
nella that lacks a functional TTSS, the MEFs failed in transforma-
tion (Figure 5A). This suggests that Salmonella injects effector
proteins during the infection cycle to support cell transformation.
Many effector proteins are injected into host cells by Salmo-
nella to invade, replicate, and survive in cells (Haraga et al.,
2008). SopB, SopE, and SopE2 are effector proteins that pro-768 Cell Host & Microbe 17, 763–774, June 10, 2015 ª2015 Elseviermote Salmonella uptake by host cells through the activation of
host Rho GTPases and the MAPKinase pathway (Zhou et al.,
2001). Host kinase AKT is activated by the Salmonella effector
SopB to inhibit fusion of the Salmonella-containing vacuole
(SCV) with lysosomes, promoting intracellular survival of the
bacterium (Kuijl et al., 2007).
Since elevated AKT and MAP kinase activities are frequently
observed in human cancers (Cseh et al., 2014; Manning
and Cantley, 2007), we tested whether Salmonella could
employ the same host pathways to initiate transformation. TheInc.
Arf/ + cMyc MEFs were infected with either WT Salmonella, a
mutant lacking four effectors (SopB, SopE, SopE2, and SptP)
collectively rendering the bacterium incapable of activating
Mapk and Akt (Zhou et al., 2001), or a mutant deficient only in
SopB (incapable of activating Akt) (Knodler et al., 2005). Since
the different effectors are also involved in bacterial uptake, we
first determined the number of bacteria of each strain required
to yield equal in vitro infection rates relative to WT Salmonella
(Figures S4D–S4F). We then infected Arf/ + cMyc MEFs with
adequate numbers of bacteria from different Salmonella strains
to yield equal infection and seeded these in a soft agar assay.
Despite equal infection rates, both Salmonella mutants were
considerably less efficient in inducing colony formation (Figures
5B and 5D).
To directly assess the role of these host Akt and Mapk kinases
in transformation, Arf/ + cMyc MEFs were infected with WT
Salmonella, followed by a soft agar colony assay performed in
the presence or absence of chemical inhibitors targeting these
kinases alone or in combination (Figures 5C, 5E, 5F, 5H, and
5I). Chemical inhibitors were applied at concentrations not
affecting growth of MEFs in monolayer conditions (Figure S5A).
Soft agar colony formation was markedly reduced by chemical
inactivation of either Akt or Map kinase and nearly abrogated
by their combined inhibition (Figure 5F). Various other inhibitors
targeting Mapk and Akt further confirmed their role in Salmo-
nella-mediated transformation of predisposed MEFs (Figures
S5B and S5D).
To directly test whether activation of the Mapk or Akt pathway
alone suffices to induce transformation in our pre-transformed
cell culture model, we selectively activated Mapk (by constitu-
tively active Mek mutant MEKdd) or Akt (by silencing Pten or
overexpressing a constitutively active Akt1 form) in Arf-deficient
MEFs either overexpressing c-MYC or not. Only the Arf-deficient
cell line overexpressing c-MYC efficiently generated colonies in
soft agar following activation of either kinase (Figures 5G, S5C,
and S5E).
The Transformed State Induced by Salmonella enterica
Persists even after Bacterial Eradication
While activation of Mapk and Akt pathways by Salmonella enter-
ica enables transformation in genetically predisposed host cells,
LPS immunostaining of gallbladder tumor samples from India did
not reveal the bacterium in the majority of cancer cells (Figures
S1C and S1D). We then hypothesized that Salmonella enterica
ignites the onset of transformation by leaving an imprint of infec-
tion in the host to allow the transformed state to persist even after
bacterial eradication.
Infected MEFs derived from soft agar colonies, having been
treated with ciprofloxacin prior to transplantation into immuno-
deficient mice, still produced tumors, suggesting that these
cells no longer needed viable Salmonella to maintain the trans-
formed state (Figure 4C). To define the minimal time of infection
required for Salmonella-induced transformation, the pre-trans-
formed MEFs were infected, and Salmonella was eliminated by
ciprofloxacin treatment at different time points post infection. A
total of 10 hr of Salmonella infection in Arf / + cMyc MEFs
already sufficed to induce nearly 60% of colony growth in soft
agar as compared to when the bacteria were left alive in the
cells (Figure 6A). This suggests that imprinting of transformationCell Hin these MEFs occurs early during the Salmonella infection
cycle.
Sustained Activated Host Signaling after Salmonella
enterica Infection in Transformed Cells and GBC
To understand the molecular basis of cellular transformation im-
printed by Salmonella infection, we isolated single cells from soft
agar colonies, eliminated the remaining Salmonella with cipro-
floxacin (Figure S4B), and seeded equal numbers of these
cells into a second-generation soft agar assay. This procedure
was repeated to produce a third-generation soft agar assay.
The number of anchorage-independent colonies increased per
generation, reaching an efficiency of 5% (successful colonies
per input cells) in the third iteration (Figure 6B). Western blot
analyses of MEFs isolated from third-generation colonies and
cultured under identical conditions as the control pre-trans-
formed MEFs confirmed constitutive activation of the Akt
pathway (Figure S6A). To test whether transformation still re-
quired an activated Akt and Map kinase pathway, we exposed
third-generation colonies to chemical inhibitors of these sig-
naling pathways. Inhibiting either Akt or Map kinase reduced
the number of colonies (Figure 6C). Even in the absence of Sal-
monella, transformation of Arf / + cMyc MEFs remained
dependent on activated Akt and Mapk pathways.
These same signaling pathways were also found activated in
GBC patient tissues from India, with 5/10 and 7/10 staining posi-
tively for p-AKT and p-MAPK, respectively (Figure 6D; Table S2).
Prevalence of these signaling markers along with the previously
identified (Figure 1; Table S1) markers in GBC tissues from these
patients underscore the importance of the features defined in the
cell culture model in achieving cellular transformation.
Salmonella enterica bacteria may then act as a vehicle for
imprinting a transformed state by virtue of sustained host cell
signaling activation. This may be due to transcriptional alter-
ations in the host as a result of infection. We then isolated two in-
dependent third-generation soft agar cultures of Arf / + cMyc
MEFs with a history of Salmonella infection and compared their
transcriptome with Arf / + cMyc MEFs that never encountered
Salmonella. Both cell samples were expanded under identical
monolayer culture conditions to ensure that differences were
related to previous Salmonella infection. The samples were sub-
jected to next-generation paired-end RNA sequencing allowing
for evaluation of point mutations, rearrangements, and expres-
sion differences. We analyzed the RNA profile of MEFs from
two independent cultures and observed a strong concordance
in altered transcription as a function of Salmonella infection his-
tory (Figure 6E). We did not reveal any Salmonella-specific se-
quences, and a small number of point mutations found in host
genes relative to the control samples had no apparent genetic
relationship to transformation or deregulation of either Mapk or
Akt pathways (Table S3). We then explored whether the tran-
scriptome was altered post-infection to sustain transformation.
Ingenuity network analysis of genes differentially expressed in
MEFs that were transformed following Salmonella infection
versus the uninfected control clustered these genes in various
functional pathways (Figure S6B), with gastrointestinal disease
and cancer as major constituents. When the differentially ex-
pressed genes were analyzed for potential networks, the
network defined by Ingenuity centered on Akt and Map kinaseost & Microbe 17, 763–774, June 10, 2015 ª2015 Elsevier Inc. 769
Figure 6. The Transformed State Induced by Salmonella Persists after Bacterial Eradication
(A) Number of soft agar colonies formed by Arf/+cMyc MEFs infected with WT S. Typhimurium (gray), not infected (white), or infected and then treated
with antibiotic ciprofloxacin (black) at 3, 6, and 10 hr post infection, as indicated. Shown are mean and SD of triplicate samples. Statistical significance by
Student’s t test, *p < 0.05.
(B) Number of soft agar colonies/well formed by S. Typhimurium-infected (bold line) or not-infected (dotted line) Arf/+cMyc MEFs. S. Typhimurium was
eliminated by ciprofloxacin, and equal numbers of MEFs were seeded in soft agar for a first (1st), second (2nd), and third (3rd) soft agar assay. Results are
(legend continued on next page)
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pathways (Figure S6C). Salmonella infection may have altered
the host transcriptome for sustained Akt and Mapk activation,
as observed in MEFs as well as human GBC tissues from India.
Previous studies reported that feedback mechanisms as a result
of cytokine production may cause sustained Akt and Mapk
activation (Cuenda and Rousseau, 2007; Zhang et al., 2011).
Indeed, almost 25% of transcripts upregulated in the trans-
formedMEFs revealed a signature of interferon-response genes.
These included the negative feedback molecules ISG15 and
USP18 to downmodulate intrinsic inflammation (Figure 6F)
(Zhang et al., 2015). The transformed MEFs thus presented an
altered transcriptome with an imprint of a normal host cell
response to bacterial infection.
Pathogens are able to epigenetically modify host cells, a phe-
nomenon called patho-epigenetics (Hamon and Cossart, 2008).
Expression changes for various epigenetic modulators were
identified in the transformed MEFs, such as HDAC family mem-
ber 9. How these different genes collectively generate a trans-
formed state dependent on activated Akt and Map kinases is
currently unclear.
DISCUSSION
Cancer arises through a multistep process involving various pre-
transforming hits. Given that only a fraction of chronic S. Typhi
carriers develop GBC, and transformation of cells typically
requires several independent steps, S. Typhi may simply con-
tribute one such step. The chance of achieving this is consider-
ably higher in chronically infected tissue, such as the gallbladder
of a chronic typhoid fever carrier. We analyzed GBC patient
samples from India and detected TP53 mutations, c-MYC over-
expression, and S. Typhi DNA in the tumors. While GBC tissues
obtained in the Netherlands also harbored TP53 mutations, they
generally lacked c-MYCoverexpression andwere never found to
contain S. Typhi DNA, suggesting that these tumors followed a
different route to transformation.
We used pre-transformed mice, gallbladder organoids, and
MEF cell cultures to show that inactivation of the Arf/TP53
pathway along with c-MYC overexpression was the minimal
requirement for S. Typhi and Typhimurium to induce definitive
transformation.Mechanistically, we established thatS.Typhimu-
rium activates host Mapk and Akt pathways to initiate transfor-
mation. These pathways are activated by Salmonella enterica-
derived effector proteins, secreted into host cells to promote
bacterial uptake and its intracellular survival. Activation of hostrepresentative of three independent experiments of technical triplicates. Shown ar
*p < 0.05; ***p < 0.001.
(C) Number of soft agar colonies/well formed by Arf/+cMycMEFswith a history
after clearance of S. Typhimurium by ciprofloxacin treatment. Not-infected Arf/
of soft agar colonies decreases in the presence of MAPK inhibitor AZD6244 (lef
triplicate samples. Statistical significance by Student’s t test; ***p < 0.01.
(D) Representative image of IHC for phospho-ERK (dark brown, top panel) and
patients as in Figure 1A. The sections are counterstained by hematoxylin for det
(E) Venn diagrams representing the overlap in 3-fold increase (left) or 10-fold dec
(FPKM) as detected by RNA sequencing of the third-generationMEFs isolated from
infected with S. Typhimurium. Right panel, combination of the up- and downreg
(F) Dot plot graph comparing up- and downregulated genes relative to the non-inf
of S. Typhimurium infection, related to Figure 6E. x axis, infected sample 1; y ax
values are plotted in log scale. See also Tables S2 and S3 and Figure S6.
Cell HAKT and MAPK pathways is also employed by other intracellular
bacterial pathogens, and such bacteria may thus be capable of
inducing cancer of infected tissues. Next to S. Typhi (Caygill
et al., 1994; Nath et al., 2008; Shukla et al., 2000),
C. trachomatis (Arnheim Dahlstro¨m et al., 2011), C. pneumoniae
(Zhan et al., 2011), andM. tuberculosis (Kuo et al., 2013) have re-
ported relationships to cervical and lung cancer. Of note, these
intracellular bacterial pathogens can all activate host AKT and
MAPK pathways during their infection cycle (Cho et al., 2010;
Du et al., 2011; Roach and Schorey, 2002). This suggests that a
direct contribution of bacteria to tumor formation could be
more common than previously anticipated and may potentially
follow principles akin to those defined in the present study.
Bacteria can also support transformation by different mecha-
nisms, such as secretion of toxins that influence host cell
processes, modification of host chromatin structure with conse-
quent manipulation of the host transcriptome (Chumduri et al.,
2013; Hamon and Cossart, 2008; Polk and Peek, 2010), and
post-translational histone modification, that may all contribute
to genetic changes and transformation of the host (Schmeck
et al., 2008). These and the host immune response to bacterial
products may further contribute to cancer formation by bacterial
infections. Of note, inflammation is not an a priori necessity to
induce transformation by Salmonella enterica, as we show here
using organoids and MEFs under conditions lacking all immune
cell components.
Although S. Typhi DNA can be detected in most GBC tissues
from India, the bacterium itself is only rarely detected in the
tumor cells. This suggests that S. Typhi may ignite transforma-
tion, but viable bacteria are not required to sustain the trans-
formed state. S. Typhimurium infection alters the host transcrip-
tome and results in a sustained activated Akt and Mapk state to
maintain transformation of cells with an inactivated Arf/TP53
axis and amplified c-MYC. These findings are phenocopied in
GBC samples from India. Whether Salmonella enterica harbors
effector proteins able to manipulate the host epigenome and
how it then instills the stably transformed phenotype is unclear.
It is possible that infection induces patho-epigenetic alterations
that —when occurring in cells with some pre-transformed char-
acteristics— can drive final transformation. The RNA profile of
MEFs shows that a history of S. Typhimurium infection stably up-
regulates a series of interferon-response genes including ISG15
and USP18. While upregulation of interferon-responsive genes
suggests some form of long-lasting intrinsic inflammation res-
ponse, ISG15 and USP18 in fact act to limit inflammation byemean and SD of triplicate samples. Statistical significance by Student’s t test;
of S. Typhimurium infection (third-generation soft agar assay indicated as ‘‘3rd’’)
+cMycMEFs were used as control for background transformation. The number
t graph) and/or Akt inhibitor AKTVIII (right graph). Shown are mean and SD of
for phospho-AKT (dark brown, bottom panel) of human GBC from the same
ection of the nuclei (in blue). Scale bar, 50 mm.
rease (center) in fragments per kilobase of exon per million fragments mapped
two different soft agar cultures and then compared to the original MEFs never
ulated genes.
ected cells from two independent samples of third-generation cells with history
is, infected sample 2. Red squares, interferon-regulated genes. Fold increase
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controlling the NF-kB pathway (Liu et al., 2013; Zhang et al.,
2015). These transcriptome modifications suggest that S. Typhi-
murium infection has complex and stable effects on cells that
contribute to transformation even after bacteria eradication.
This study provides and explains a direct bacterial contribu-
tion to the formation of cancer. We define the minimal host cell
requirements, i.e., mutations along the Arf/TP53 and c-MYC
axes, which match with samples from GBC patients collected
in India. GBC may therefore result as collateral damage of the
normal Salmonella enterica infection cycle that drives definitive
transformation when infecting pre-transformed cells.
Improved control of (chronic) S. Typhi infection in areas where
it is endemic may thus reduce the local incidence of GBC, a can-
cer type with poor prognosis at present.
EXPERIMENTAL PROCEDURES
Ethical Considerations and Specimens Collection
The human gallbladder specimens were collected between January 2009 and
July 2013 at the University Hospital of Banaras Hindu University, Varanasi.
The study design was approved by the Institute Ethics Committee, and a
well-informed written consent was obtained from each of the patients. Dutch
gallbladder tissue samples were obtained from the NKI-AVL biobank after
approval of the Translational Research Board according to Dutch legislation
and registered under number CFMPB67.
IHC, Microscopy, Antibodies, and Antibiotics
Preparation of tissues and organoids for IHC was according to standard pro-
cedures, and details are reported in Supplemental Experimental Procedures.
Details of samples preparation for microscopy and antibodies used for IHC,
western blot, and microscopy can be found in Supplemental Experimental
Procedures. Antibiotic ciprofloxacin (Tokyo Chemical Industry) was added to
infected cells 10 hr post-infection at a final concentration of 50 mg/ml.
Animal Experiments
All mice were used according to protocols approved by the Institutional Animal
Use Committee of the Netherlands Cancer Institute and maintained in path-
ogen-free isolators within the animal facility. For tumor growth experiments,
Rag1/gc/ mice (bred in-house) were implanted s.c. on the flank with
53106MEFs in 100 ml PBS. ForWT and/orDprgHS. Typhimurium 14028 infec-
tion experiments,Apc+/min FVBmice crossedwith 129Olamice were used (see
also Supplemental Experimental Procedures).
Gallbladder Organoids and Cell Lines
Gallbladder organs from Ink4b-Arf-Ink4a KO mice on FVB background (Krim-
penfort et al., 2007) were handled for organoid growth as described (Koo et al.,
2012; Sato et al., 2009). Noggin and RSpondin were excluded from the
medium since they attenuated growth of gallbladder organoids. For details
on organoids and MEF culture conditions, see Supplemental Experimental
Procedures.
Salmonella enterica Infection of MEFs and Gallbladder Organoids
S. Typhi and S. Typhimurium infection of the MEFs was performed as
described (Kuijl et al., 2007). Details of S. Typhimurium infection of MEFs
and gallbladder organoids are described in the Supplemental Experimental
Procedures.
Anchorage-Independent Assays
After S. Typhimurium infection at the different time points indicated, the MEFs
diluted in DMEMwith 10%FBS and 10 mg/ml gentamicin were seeded in a sus-
pension layer of 0.4% soft agar (UltraPure Low Melting Point Agarose, Invitro-
gen) on top of 0.7% soft agar bottom layer in six-well plates (50,000 cells
seeded per well). Anchorage-independent cell growth and number of soft
agar colonies were assessed after 2 weeks of culture and quantified and
imaged as described in Supplemental Experimental Procedures.772 Cell Host & Microbe 17, 763–774, June 10, 2015 ª2015 ElsevierInhibitors
Toxicity of the inhibitors was determined on MEFs growing under standard
2D tissue culture conditions using CellTiter-Blue Cell Viability Assays (Prom-
ega) and in S. Typhimurium cultures in LB medium by measuring growth at
OD 600.
For inhibitor names and concentrations see Supplemental Experimental
Procedures.
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The accession number for the deep sequencing data reported in this paper is
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Supplemental Information includes six figures, three tables, one movie, and
Supplemental Experimental Procedures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.chom.2015.05.002.
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